These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28460073)
61. Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: therapeutic implication for scar reduction. Cheng J; Wang Y; Wang D; Wu Y Am J Med Sci; 2013 Aug; 346(2):98-103. PubMed ID: 23221517 [TBL] [Abstract][Full Text] [Related]
62. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity. Jing X; Yang J; Jiang L; Chen J; Wang H Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410 [TBL] [Abstract][Full Text] [Related]
63. Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction. Zhang L; Yin H; Jiao L; Liu T; Gao Y; Shao Y; Zhang Y; Shan H; Zhang Y; Yang B Cell Physiol Biochem; 2018; 45(4):1641-1653. PubMed ID: 29486470 [TBL] [Abstract][Full Text] [Related]
64. MiR-185-5p regulates the development of myocardial fibrosis. Lin R; Rahtu-Korpela L; Szabo Z; Kemppi A; Skarp S; Kiviniemi AM; Lepojärvi ES; Halmetoja E; Kilpiö T; Porvari K; Pakanen L; Tolva J; Paakkanen R; Segersvärd H; Tikkanen I; Laine M; Sinisalo J; Lakkisto P; Huikuri H; Magga J; Junttila J; Kerkelä R J Mol Cell Cardiol; 2022 Apr; 165():130-140. PubMed ID: 34973276 [TBL] [Abstract][Full Text] [Related]
65. The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction. Zhang S; Cui R Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):523-531. PubMed ID: 29424913 [TBL] [Abstract][Full Text] [Related]
66. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276 [TBL] [Abstract][Full Text] [Related]
67. Ultrasound-Induced Microbubble Cavitation for Targeted Delivery of MiR-29b Mimic to Treat Cardiac Fibrosis. Feroze RA; Kopechek J; Zhu J; Chen X; Villanueva FS Ultrasound Med Biol; 2023 Dec; 49(12):2573-2580. PubMed ID: 37749011 [TBL] [Abstract][Full Text] [Related]
68. A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials. Geng X; Shi E; Wang S; Song Y PLoS One; 2020; 15(5):e0233705. PubMed ID: 32470067 [TBL] [Abstract][Full Text] [Related]
69. The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-β1 in the myocardium of rats with diabetes. Wang L; Yuan T; Du G; Zhao Q; Ma L; Zhu J Diabetes Res Clin Pract; 2014 May; 104(2):226-33. PubMed ID: 24613393 [TBL] [Abstract][Full Text] [Related]
70. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Yildirim SS; Akman D; Catalucci D; Turan B Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006 [TBL] [Abstract][Full Text] [Related]
71. miR-26a attenuates cardiac apoptosis and fibrosis by targeting ataxia-telangiectasia mutated in myocardial infarction. Chiang MH; Liang CJ; Lin LC; Yang YF; Huang CC; Chen YH; Kao HL; Chen YC; Ke SR; Lee CW; Lin MS; Chen YL J Cell Physiol; 2020 Sep; 235(9):6085-6102. PubMed ID: 31990056 [TBL] [Abstract][Full Text] [Related]
72. MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis. Dong H; Dong S; Zhang L; Gao X; Lv G; Chen W; Shao S Anat Rec (Hoboken); 2016 Oct; 299(10):1348-57. PubMed ID: 27357906 [TBL] [Abstract][Full Text] [Related]
73. MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1. Yuan CT; Li XX; Cheng QJ; Wang YH; Wang JH; Liu CL Int J Clin Exp Pathol; 2015; 8(12):15527-36. PubMed ID: 26884822 [TBL] [Abstract][Full Text] [Related]
74. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α. Aoshima Y; Mizobuchi M; Ogata H; Kumata C; Nakazawa A; Kondo F; Ono N; Koiwa F; Kinugasa E; Akizawa T Nephrol Dial Transplant; 2012 May; 27(5):1800-6. PubMed ID: 22287655 [TBL] [Abstract][Full Text] [Related]
75. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway. Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897 [TBL] [Abstract][Full Text] [Related]
76. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα. Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067 [TBL] [Abstract][Full Text] [Related]
77. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice. Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785 [TBL] [Abstract][Full Text] [Related]
78. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure. Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073 [TBL] [Abstract][Full Text] [Related]
79. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123 [TBL] [Abstract][Full Text] [Related]
80. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]